Click the play button below to stream the episode via SoundCloud!
Andy Slavitt, the former head of Medicare, Medicaid, and the Affordable Care Act (ACA) under President Obama, joins us for a very special interview segment on the importance of the ACA for people with hemophilia. UK-based community advocate Laurence Woollard provides insight into the UK bleeding disorders community and his personal journey in hemophilia advocacy. Natalie leads a New York Times story on the debate surrounding how to price gene therapy treatments, and Patrick provides an overview of the recent, terrible news of a patient death during the Fitusrian clinical trial - what happened, what it means, and what happens next? Listen now on Episode 16 of The BloodStream Podcast.
Exclusive Sponsor for Episode 16: Shire
Like Share Comment
Comment: Alnylam Suspends All Trials of Fitusiran After Hemophilia A Patient Dies in Phase 2 Study // Story from RareDr.com // Story from FierceBiotech
Andy Slavitt Interview
Other Links of Interest
Powering Through Podcast: http://poweringthrough.org/podcast
Ask The Expert Podcast: http://bloodstreamexpert.com
Connect with BloodStream:
Find all of our bleeding disorders podcasts on BloodStreamMedia.com
Subscribe to BloodStream:
Google Play: http://bit.ly/bloodstreamPlay